Name | 2-(Diethylamino)ethyl N-(2-chloro-6-methylbenzoyl)-4-[(2,6-dichlo robenzoyl)amino]-L-phenylalaninate hydrochloride (1:1) |
---|
Description | Valategrast hydrochloride (R-411) is a potent integrin α4β1 (VLA-4) and α4β7 dual antagonist. Valategrast hydrochloride has the potential for Chronic obstructive pulmonary disease (COPD) and asthma treatment[1][2]. |
---|---|
Related Catalog | |
Target |
α4β1 α4β7 |
In Vitro | Valategrast (hydrochloride) contains a common l-phenylalanine-N-aroyl motif where the carboxylic acid is responsible for binding to the metal ion in the metal-ion-dependent adhesion site (MIDAS)[2]. |
References |
Molecular Formula | C30H33Cl4N3O4 |
---|---|
Molecular Weight | 641.41300 |
Exact Mass | 639.12300 |
PSA | 91.23000 |
LogP | 7.88340 |